We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Antonio Silvestre

Antonio Salar Silvestre MD

Associate Professor of Hematology, Universidad Autónoma de Barcelona; Head of Section, Department of Clinical Hematology, Hospital del Mar, Barcelona

Antonio Salar is specialist in Hematology. His current positions are Head of Section of the Department of Clinical Hematology at the Hospital del Mar, Barcelona and Associate Professor of Hematology in the Universidad Autónoma de Barcelona. 

He is member and Coordinator of the Indolent Lymphomas Subcommittee of the GELTAMO group (Grupo Español de Linfomas y Trasplante de Médula Ósea) and participates as principal investigator in clinical trials on lymphomas.

Dr. Salar has contributed with approximately 80 publications in national and international medical journals. His main topic of interest is clinical and translational research in indolent lymphomas, and in particular MALT lymphomas.

Disclosures

1. Serve(d) as Consultant or Advisory Role for: Roche, Amgen and Mundipharma.

Recent Contributions to PracticeUpdate:

  1. SC vs IV Rituximab As Maintenance for Follicular Lymphoma